4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0000950170-24-064669
Director acquired 21,887 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chrousos Phaedra Director | 2024-05-22 | Grant or award | +21,887 | 64,125 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Chrousos Phaedra Director | 2024-05-22 | Grant or award · Stock Option (right to buy) | +40,202 | 40,202 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…